Recent reporting, background, and summaries from the health desk.
A second human case of H5N1 bird flu, linked to infected dairy cattle, has been confirmed in the U.S., sparking renewed concerns about the virus's spread. This Michigan farm worker experienced mild respiratory symptoms and has since recovered, prompting health officials to emphasize protective measures as they closely monitor the virus's circulation in livestock.
The U.S. Supreme Court unanimously upheld access to mifepristone, a widely used abortion pill, by rejecting a major challenge to the FDA's regulations. This pivotal decision ensures the medication remains available nationwide, as the justices ruled that anti-abortion plaintiffs lacked the legal standing to sue.
World leaders at the 80th United Nations General Assembly have adopted a historic political declaration to collectively address noncommunicable diseases (NCDs) and mental health challenges for the first time. This landmark agreement, adopted on December 16, 2025, sets ambitious global targets for 2030, including reducing tobacco users by 150 million and expanding mental health care access to an additional 150 million people, aiming to transform lives and livelihoods worldwide.
The NHS is currently grappling with a "worst case scenario" this December, as a severe "super flu" surge and escalating Norovirus cases have led to record hospitalizations, with flu admissions up over 55% in just one week. This critical strain on healthcare services is further compounded by an impending five-day strike by resident doctors, threatening to severely disrupt patient care during the health service's busiest period.
The Pan American Health Organization (PAHO) has urgently called on countries in the Americas to address critical vaccination gaps as whooping cough cases have dramatically surged, reaching nearly six times the 2023 numbers globally and over 66,000 in the Americas in 2024. This alarming resurgence, particularly affecting infants and vulnerable communities, is attributed to declining immunization coverage during the COVID-19 pandemic, which remains below PAHO's recommended 95% target.
In a landmark decision on November 12, 2025, the United States Conference of Catholic Bishops (USCCB) formally prohibited gender-affirming care across its extensive network of over 650 Catholic hospitals, a move impacting one in six acute care hospitals in the U.S. This directive, overwhelmingly supported by bishops, has sparked immediate and strong reactions, drawing praise from conservative groups while facing severe criticism from LGBTQ+ advocates and medical organizations concerned about patient well-being and access to care for transgender individuals.
New data presented at a major international conference reveals that the Alzheimer's drug lecanemab (Leqembi) could dramatically slow disease progression by over eight years for certain patients, offering a far more optimistic outlook than previously understood. These groundbreaking findings, which highlight the profound impact of early intervention and include the development of a convenient at-home injectable version, underscore the critical need for early diagnosis despite concerns over the drug's high annual cost.
A new report from the WHO and World Bank, released on December 6, 2025, reveals a mixed global picture for universal health coverage, with billions still lacking essential care despite some progress in expanding access since 2000. The report highlights that 4.6 billion people remain without vital health services and 2.1 billion face severe financial hardship, indicating that the world is significantly off track to meet its 2030 UHC goals due to stagnant public health spending and disproportionate burdens on the poorest populations.
Decades of progress in HIV/AIDS care, particularly across Africa, are severely jeopardized by drastic reductions in international aid, threatening to reverse hard-won gains. Experts warn that these critical funding cuts, largely due to a halt in US contributions, could lead to an alarming 3.3 million additional HIV infections by 2030, sparking a global health emergency.
The World Health Organization has officially recognized GLP-1 weight loss medications, including Mounjaro and Wegovy, as a significant breakthrough in combating the escalating global obesity crisis, marking a pivotal shift in how the international health body views treatment. Amidst projections that global obesity will affect two billion people by 2030, the WHO is now urging countries to enhance access to these therapies and calling on pharmaceutical companies to lower prices and increase production to ensure equitable availability worldwide.
Global efforts to combat HIV, tuberculosis, and malaria are severely jeopardized due to a significant $6.7 billion funding deficit in the Global Fund's 2026-2028 budget, threatening to reverse years of public health advancements. This critical shortfall, largely attributed to the reluctance of key donor nations to commit specific amounts, raises serious concerns about the sustainability of life-saving programs and the potential resurgence of these devastating diseases.
A major series of papers in The Lancet, involving 43 international experts, reveals a global health crisis where the rapid increase in ultra-processed food (UPF) consumption is displacing fresh foods and linked to a surge in chronic health problems, impacting nearly every major organ system. Scientists are urgently calling for bold, coordinated policy action to counter significant corporate influence and shift food systems towards healthier options, as UPFs now constitute over 50% of the average diet in countries like the UK and US.